Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Exelixis (EXEL) is now available.
At Exelixis, Inc.’s 2024 Annual Meeting, shareholders voted to expand the Employee Stock Purchase Plan, authorizing an additional 6 million shares for issuance. The board of directors saw the re-election of 11 members, and Ernst & Young LLP was ratified as the independent accounting firm for the upcoming fiscal year. Additionally, the compensation of Exelixis’ executive officers received advisory approval from the stockholders. These decisions reflect the active engagement of Exelixis’ investors in the company’s governance and strategic incentive programs.
For an in-depth examination of EXEL stock, go to TipRanks’ Stock Analysis page.